
To help ensure patient safety, a Coram clinician may notify a patient and/or their physician of these labeling updates when appropriate.
Drug Name | Active Ingredient | Supplement Date | Database Updated |
INFLECTRA | INFLIXIMAB-DYYB | 09/03/2025 | 09/05/2025 |
RYBREVANT | AMIVANTAMAB-VMJW | 09/03/2025 | 09/08/2025 |
SKYRIZI | RISANKIZUMAB-RZAA | 09/03/2025 | 09/05/2025 |
SKYRIZI | RISANKIZUMAB-RZAA | 09/03/2025 | 09/05/2025 |
VIGAFYDE | VIGABATRIN | 09/03/2025 | 09/05/2025 |
GATTEX KIT | TEDUGLUTIDE RECOMBINANT | 09/05/2025 | 09/10/2025 |
SUSVIMO | RANIBIZUMAB | 09/05/2025 | 09/10/2025 |
EPKINLY | EPCORITAMAB-BYSP | 09/11/2025 | 09/15/2025 |
LUPRON DEPOT | LEUPROLIDE ACETATE | 09/10/2025 | 09/12/2025 |
LUPRON DEPOT | LEUPROLIDE ACETATE | 09/10/2025 | 09/12/2025 |
LUPRON DEPOT | LEUPROLIDE ACETATE | 09/10/2025 | 09/12/2025 |
RETIN-A MICRO | TRETINOIN | 09/10/2025 | 09/12/2025 |
Reference: Drug Safety-related Labeling Changes (SrLC) (fda.gov)
This article contains references to brand-name prescription drugs that are trademarks or registered trademarks of pharmaceutical manufacturers not affiliated with Coram.